SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-040152
Filing Date
2023-05-16
Accepted
2023-05-16 08:08:28
Documents
170
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f20f2022_altamirather.htm   iXBRL 20-F 2878970
2 DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12 OF THE EXCHANGE ACT f20f2022ex2-13_altamira.htm EX-2.13 130636
3 AMENDMENT NO. 6 TO CONVERTIBLE LOAN AGREEMENT, BETWEEN ALTAMIRA THERAPEUTICS LTD f20f2022ex4-38_altamira.htm EX-4.38 16246
4 FORM OF AMENDMENT NO. 1 TO LOAN AGREEMENT, DATED DECEMBER 28, 2022 f20f2022ex4-40_altamira.htm EX-4.40 11604
5 AMENDMENT NO. 2 TO LOAN AGREEMENT, BETWEEN ALTAMIRA THERAPEUTICS LTD. AND THE LE f20f2022ex4-41_altamira.htm EX-4.41 28338
6 LIST OF SUBSIDIARIES f20f2022ex8-1_altamira.htm EX-8.1 2806
7 CERTIFICATION f20f2022ex12-1_altamira.htm EX-12.1 9649
8 CERTIFICATION f20f2022ex12-2_altamira.htm EX-12.2 9743
9 CERTIFICATION f20f2022ex13-1_altamira.htm EX-13.1 3453
10 CERTIFICATION f20f2022ex13-2_altamira.htm EX-13.2 3603
11 CONSENT OF DELOITTE AG f20f2022ex15-1_altamira.htm EX-15.1 5190
12 GRAPHIC image_001.jpg GRAPHIC 9135
  Complete submission text file 0001213900-23-040152.txt   13222406

Data Files

Seq Description Document Type Size
13 XBRL SCHEMA FILE cyto-20221231.xsd EX-101.SCH 223246
14 XBRL CALCULATION FILE cyto-20221231_cal.xml EX-101.CAL 41724
15 XBRL DEFINITION FILE cyto-20221231_def.xml EX-101.DEF 546287
16 XBRL LABEL FILE cyto-20221231_lab.xml EX-101.LAB 1117317
17 XBRL PRESENTATION FILE cyto-20221231_pre.xml EX-101.PRE 576489
164 EXTRACTED XBRL INSTANCE DOCUMENT f20f2022_altamirather_htm.xml XML 2038656
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000 41 (0) 41 729 71 94
Altamira Therapeutics Ltd. (Filer) CIK: 0001601936 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36582 | Film No.: 23925630
SIC: 2834 Pharmaceutical Preparations